U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H17F2N3O3
Molecular Weight 385.3641
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SARAFLOXACIN

SMILES

OC(=O)C1=CN(C2=CC=C(F)C=C2)C3=C(C=C(F)C(=C3)N4CCNCC4)C1=O

InChI

InChIKey=XBHBWNFJWIASRO-UHFFFAOYSA-N
InChI=1S/C20H17F2N3O3/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24/h1-4,9-11,23H,5-8H2,(H,27,28)

HIDE SMILES / InChI

Molecular Formula C20H17F2N3O3
Molecular Weight 385.3641
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Sarafloxacin [A 55620] is a quinolone antibiotic that was under development with Abbott Laboratories in the USA. It was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001. It was never approved for use in the US or Canada.

Approval Year

PubMed

PubMed

TitleDatePubMed
Effects of fish CYP inducers on difloxacin N-demethylation in kidney cell of Chinese idle (Ctenopharyngodon idellus).
2010-09
Determination of fluoroquinolone residues in poultry muscle in Portugal.
2010-07
Laser induced fluorescence coupled to capillary electrophoresis for the determination of fluoroquinolones in foods of animal origin using molecularly imprinted polymers.
2010-04-09
Aquatic photochemistry of fluoroquinolone antibiotics: kinetics, pathways, and multivariate effects of main water constituents.
2010-04-01
Single-step extraction followed by LC for determination of (fluoro)quinolone drug residues in muscle, eggs, and milk.
2010-04
Behaviour of (14)C-sulfadiazine and (14)C-difloxacin during manure storage.
2010-03-01
Fluoroquinolone antibiotics determination in piggeries environmental waters.
2010-03
Simultaneous determination of quinolones for veterinary use by high-performance liquid chromatography with electrochemical detection.
2010-02-01
Sensitive determination of fluoroquinolone residues in waters by capillary electrophoresis with laser-induced fluorescence detection.
2010-02
High prevalence of multidrug-tolerant bacteria and associated antimicrobial resistance genes isolated from ornamental fish and their carriage water.
2009-12-21
Simultaneous determination of eleven quinolones in animal feed by liquid chromatography with fluorescence and ultraviolet absorbance detection.
2009-11-13
Fluoroquinolone antibiotic determination in bovine, ovine and caprine milk using solid-phase extraction and high-performance liquid chromatography-fluorescence detection with ionic liquids as mobile phase additives.
2009-10-23
Photolysis of difloxacin and sarafloxacin in aqueous systems.
2009-10
Microbial screening methods for detection of antibiotic residues in slaughter animals.
2009-10
In vitro residual anti-bacterial activity of difloxacin, sarafloxacin and their photoproducts after photolysis in water.
2009-10
Quantification of danofloxacin and difloxacin in chicken tissues in the presence of sarafloxacin as interference.
2009-09-09
Rapid method for the determination and confirmation of fluoroquinolone residues in catfish using liquid chromatography/fluorescence detection and liquid chromatography-tandem mass spectrometry.
2009-09-01
Quantitation and identity confirmation of residues of quinolones in tilapia fillets by LC-ESI-MS-MS QToF.
2009-08
Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.
2009-07-30
[Simultaneous analysis of 7 fluoroquinolone residues in chicken muscle by ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry].
2009-07
Primary photoprocesses in a fluoroquinolone antibiotic sarafloxacin.
2009-06-11
Application of ionic liquids in high performance reversed-phase chromatography.
2009-06-04
Solid-phase microextraction with micellar desorption and HPLC-fluorescence detection for the analysis of fluoroquinolones residues in water samples.
2009-06
Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma.
2009-04-01
Metabolism and excretion kinetics of 14C-labeled and non-labeled difloxacin in pigs after oral administration, and antimicrobial activity of manure containing difloxacin and its metabolites.
2009-04
Multiclass analysis of antibiotic residues in honey by ultraperformance liquid chromatography-tandem mass spectrometry.
2009-03-11
Rapid determination of 19 quinolone residues in spiked fish and pig muscle by high-performance liquid chromatography (HPLC) tandem mass spectrometry.
2009-03
[Multi-residue determination of 11 quinolones in chicken muscle by high performance liquid chromatography with fluorescence detection].
2009-03
Ultra performance liquid chromatography tandem mass spectrometry performance evaluation for analysis of antibiotics in natural waters.
2009-03
Simultaneous determination of 13 quinolones in eggs using column high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry and depletion of pefloxacin methanesulfonate in eggs.
2009-02-11
Developing and optimizing an immunoaffinity cleanup technique for determination of quinolones from chicken muscle.
2009-01-28
Determination of fluoroquinolones in aquaculture products by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
2009-01
[Simultaneous determination of 19 quinolone residues in honey using high performance liquid chromatography-tandem mass spectrometry].
2009-01
Water-compatible molecularly imprinted polymer for the selective recognition of fluoroquinolone antibiotics in biological samples.
2009-01
Trace analysis of quinolone and fluoroquinolone antibiotics from wastewaters by liquid chromatography-electrospray tandem mass spectrometry.
2008-12-19
Ionic liquids as mobile phase additives for the high-performance liquid chromatographic analysis of fluoroquinolone antibiotics in water samples.
2008-12
Simultaneous determination of quinolone antibacterials in bovine milk by liquid chromatography-mass spectrometry.
2008-11
Development and validation of a solid-phase extraction method coupled to liquid chromatography with fluorescence detection for the determination of fluoroquinolone residues in powdered infant formulae. Application to the analysis of samples from the Spanish and Latin American market.
2008-10-31
Solid-phase extraction of fluoroquinolones from aqueous samples using a water-compatible stochiometrically imprinted polymer.
2008-10-24
Multi-residue determination of seven quinolones antibiotics in gilthead seabream using liquid chromatography-tandem mass spectrometry.
2008-09-05
[Multiresidue determination of quinolones in animal and fishery products by HPLC].
2008-06
In-line solid-phase extraction preconcentration in capillary electrophoresis-tandem mass spectrometry for the multiresidue detection of quinolones in meat by pressurized liquid extraction.
2008-05
Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.
2008-05
Multiclass determination and confirmation of antibiotic residues in honey using LC-MS/MS.
2008-03-12
Development of an HPLC multi-residue method for the determination of ten quinolones in bovine liver and porcine kidney according to the European Union Decision 2002/657/EC.
2008-01
Validation of an HPLC-UV method according to the European Union Decision 2002/657/EC for the simultaneous determination of 10 quinolones in chicken muscle and egg yolk.
2007-11-15
Multiresidue method for simultaneous determination of quinolone antibacterials in pig kidney samples by liquid chromatography with fluorescence detection.
2007-11-15
Development and validation of an HPLC confirmatory method for residue analysis of ten quinolones in tissues of various food-producing animals, according to the European Union Decision 2002/657/EC.
2007-11
Multiresidue HPLC analysis of ten quinolones in milk after solid phase extraction: validation according to the European Union Decision 2002/657/EC.
2007-10
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
2007-07
Patents

Sample Use Guides

Rats: 40 mg/kg, injected intramuscularly three times a day at 4-h intervals.
Route of Administration: Intramuscular
The MIC of sarafloxacin against five isolates and two reference strains of Mycoplasma gallisepticum (MG) (approximately 10(5) colony-forming units [CFU]/ml) was 0.37 ug/ml
Substance Class Chemical
Created
by admin
on Wed Apr 02 09:20:18 GMT 2025
Edited
by admin
on Wed Apr 02 09:20:18 GMT 2025
Record UNII
RC3WJ907XY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ABBOTT-57135
Preferred Name English
SARAFLOXACIN
HSDB   INN   MI  
INN  
Official Name English
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
Systematic Name English
DIFLOXACIN HYDROCHLORIDE TRIHYDRATE FOR VETERINARY USE IMPURITY B [EP IMPURITY]
Common Name English
3-QUINOLINECARBOXYLIC ACID, 6-FLUORO-1-(4-FLUOROPHENYL)-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-
Systematic Name English
6-FLUORO-1-(P-FLUOROPHENYL)-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-3-QUINOLINECARBOXYLIC ACID
Systematic Name English
sarafloxacin [INN]
Common Name English
SARAFLOXACIN [HSDB]
Common Name English
SARAFLOXACIN [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C795
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
Code System Code Type Description
SMS_ID
300000029416
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
ChEMBL
CHEMBL37858
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
NCI_THESAURUS
C84143
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
MESH
C047224
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
FDA UNII
RC3WJ907XY
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
HSDB
7035
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
INN
6568
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
MERCK INDEX
m9777
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY Merck Index
CAS
98105-99-8
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
PUBCHEM
56208
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
WIKIPEDIA
SARAFLOXACIN
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
DRUG BANK
DB11491
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID8048494
Created by admin on Wed Apr 02 09:20:18 GMT 2025 , Edited by admin on Wed Apr 02 09:20:18 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY